PAPPA and lung cancer: In breast cancer, an elevated serum PAPP-A has been shown to be associated with low recurrence-free and overall survival [20], and recently, we demonstrated that serum PAPP-A2 is higher in patients with lung cancer and predictive of all-cause mortality [13].